Rigel Pharmaceuticals Stock (NASDAQ: RIGL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 170.07K |
Day Range | - - - |
52 Wk Range | 7.12 - 17.30 |
Market Cap | $240.35M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 3.4% |
Days to Cover | 6.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rigel Pharmaceuticals (NASDAQ:RIGL) through any online brokerage.
Other companies in Rigel Pharmaceuticals’s space includes: Zura Bio (NASDAQ:ZURA), Adaptimmune Therapeutics (NASDAQ:ADAP), Kyverna Therapeutics (NASDAQ:KYTX), TScan Therapeutics (NASDAQ:TCRX) and Genfit (NASDAQ:GNFT).
Rigel Pharmaceuticals has a consensus price target of $12.04.
The stock price for Rigel Pharmaceuticals (NASDAQ: RIGL) is $13.66 last updated September 23, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Rigel Pharmaceuticals.
Rigel Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Rigel Pharmaceuticals.
Rigel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.